Ruthann M McGarry

Title: Ruthann M McGarry: Innovator in Cardiotonic Research

Introduction

Ruthann M McGarry is a notable inventor based in Schodack, NY (US). She has made significant contributions to the field of cardiotonics, with a focus on the development of novel compounds that have potential therapeutic applications. With a total of two patents to her name, her work exemplifies innovation in pharmaceutical research.

Latest Patents

Ruthann's latest patents include the preparation of 5-(hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones. These patents disclose and claim the cardiotonic use of 1-R.sub.1 -5-(3-R'-4-R'-phenyl)-6-R-2(1H)-pyridinones, where R.sub.1 is hydrogen, lower-alkyl, or lower-hydroxyalkyl. The compounds are designed to have various substitutions that enhance their pharmacological properties. The processes for synthesizing these compounds involve reacting specific precursors with phosphoric acid, leading to the desired cardiotonic agents.

Career Highlights

Ruthann M McGarry has had a distinguished career at Sterling Drug Inc., where she has been instrumental in advancing research in cardiotonics. Her innovative approaches to drug development have contributed to the understanding of how these compounds can be utilized in medical treatments.

Collaborations

Throughout her career, Ruthann has collaborated with notable colleagues, including George Y Lesher and Chester J Opalka, Jr. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Ruthann M McGarry's contributions to the field of cardiotonics highlight her role as an innovative inventor. Her patents reflect a commitment to advancing medical science and improving therapeutic options for patients.